Ansell Limited (ASX:ANN) Prepares for FY26 Results as Investors Track Healthcare Equipment Outlook

Anjali Anand

11 August 2026 11:13 PM AEST

Ansell Limited (ASX:ANN) Prepares for FY26 Results as Investors Track Healthcare Equipment Outlook

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Ansell Limited (ASX:ANN) is scheduled to release its FY26 full year results for the period ended 30 June 2026 on 24 August 2026.
The company has provided details for an investor webcast to discuss the FY26 results following the announcement.
Ansell operates in the healthcare equipment and services sector, focusing on personal protection equipment solutions.
The company’s shares were trading at $34.880, with a Market Capitalisation of $4.84B based on the provided market data.
Ansell has operations across healthcare and industrial workplace safety markets through its product portfolio.

Ansell Limited (ASX:ANN) Sets Date for FY26 Full Year Results

Ansell Limited (ASX:ANN) has announced the scheduled release of its FY26 full year results for the period ended 30 June 2026. The company confirmed that the results will be released on Monday 24 August 2026, followed by an investor webcast at 9:00am Australian Eastern Standard Time. (Market Index)

The upcoming results announcement will provide investors and Stakeholders with an update on the company’s financial performance and Business activities for FY26. The webcast will be hosted by Managing Director and Chief Executive Officer Nathalie Ahlström and Acting Chief Financial Officer Fred Marx to discuss the results following the release. (Market Index)

Company Overview and Business Operations

Ansell Limited is listed on the Australian Securities Exchange under the ticker ASX:ANN and operates within the healthcare equipment and services sector. The company manufactures personal protection equipment designed for healthcare and industrial workplaces.

The company’s operations are focused on providing safety solutions through a range of protective products used across different workplace environments. Ansell serves customers across healthcare and industrial markets, with its products covering areas associated with workplace protection and safety requirements.

The company’s business model includes product development, Manufacturing activities and distribution across international markets. Ansell has stated that its products are used by workers in more than 100 countries, supporting workplace safety requirements across multiple industries.

Ansell Share Market Information

Based on the provided market data, Ansell Limited (ASX:ANN) was trading at $34.880, reflecting a daily movement of +$0.320 or 0.925%. The company recorded trading Volume of 311,471 shares, while its market capitalisation stood at $4.84B.

The stock traded within a daily range of $34.330 to $34.890, compared with the previous close of $34.560. The provided 52-week trading range was between $25.050 and $37.540.

Ansell has 140,313,831 shares on issue, with its ordinary fully paid shares listed on the Australian Securities Exchange. The company was listed on 22 August 1985.

FY26 Results Announcement and Investor Focus Areas

The FY26 full year results announcement represents the company’s scheduled update for the financial period ended 30 June 2026. The release is expected to provide information on financial outcomes, operational developments and business priorities during the period.

Investors following ASX:ANN will be able to review the company’s latest reported performance, management commentary and any updates regarding future business activities after the results are released. The webcast provides an opportunity for stakeholders to hear management’s discussion of the announced results.

The announcement of the results date is part of Ansell’s regular financial reporting calendar, with the company previously publishing scheduled dates for its financial updates. (Investor Centre)

Position Within the Healthcare Equipment Sector

Ansell operates within the healthcare equipment and services segment, which includes companies involved in products and solutions supporting healthcare delivery and workplace requirements.

The company’s focus on protective equipment places it across both healthcare and industrial applications. Demand patterns in these markets can be influenced by workplace safety requirements, healthcare activity, manufacturing conditions and broader economic factors.

Through its manufacturing and distribution network, Ansell continues to participate in global safety product markets while reporting its financial performance through regular ASX disclosures.

Looking Ahead to FY26 Results

The upcoming FY26 results announcement will provide further details on Ansell’s financial performance for the year ended 30 June 2026. Until the release, available information remains focused on the scheduled announcement date, webcast arrangements and company background.

The results update will be an important source of information for understanding the company’s recent operating activities, financial outcomes and management commentary. Investors and Market Participants can refer to the company’s official disclosures following the announcement for additional details. (Investor Centre)

Conclusion

Ansell Limited (ASX:ANN) is preparing to release its FY26 full year results on 24 August 2026, providing an update on its performance for the year ended 30 June 2026. The company operates in the healthcare equipment and services sector, with activities focused on personal protection equipment solutions for healthcare and industrial workplaces. The upcoming results announcement and investor webcast will provide further information on the company’s financial performance and operational developments during FY26.

FAQs

Q: What is the ASX ticker code for Ansell Limited?

A:Ansell Limited is listed on the Australian Securities Exchange under the ticker code ASX:ANN.

Q: When will Ansell Limited release its FY26 full year results?

A:Ansell Limited is scheduled to release its FY26 full year results for the period ended 30 June 2026 on Monday 24 August 2026. (Market Index)

Q: What sector does Ansell Limited operate in?

A:Ansell Limited operates within the healthcare equipment and services sector.

Q: What will be discussed during the Ansell FY26 results webcast?

A:The webcast will include management commentary on the FY26 full year results following the release of the announcement.

Q: Does this article provide financial advice about Ansell Limited?

A:No. This article is intended for general educational purposes only and does not provide financial advice, valuation, or any recommendation regarding securities.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.